News from kalobios pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 22, 2015, 18:00 ET
KaloBios logo.

KaloBios Elects Ronald A. Martell to Board of Directors

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the election of veteran biopharmaceutical industry executive, Ronald A. Martell,...

Apr 06, 2015, 08:01 ET
KaloBios logo.

KaloBios to Present at the 14th Annual Needham Healthcare Conference

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that it will present at the 14th Annual Needham Healthcare Conference in New...

Mar 16, 2015, 14:47 ET
KaloBios logo.

KaloBios Reports Fourth Quarter 2014 Financial Results

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today reported its financial results for the fiscal year 2014. Net loss for the fiscal year ended...

Feb 03, 2015, 16:01 ET
KaloBios logo.

KaloBios Announces Upcoming Investor Conference Participation

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that it will present at the BIO CEO & Investor Conference, and will participate...

Jan 08, 2015, 16:31 ET
KaloBios logo.

KaloBios Announces Retirement of David W. Pritchard, President and Chief Executive Officer

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that David W. Pritchard, president and chief executive officer, has decided to...

Jan 06, 2015, 16:01 ET
KaloBios logo.

KaloBios Reports Top-Line Data for Phase 2 Study of KB001-A to Treat Pseudomonas Aeruginosa Lung Infections in Cystic Fibrosis Patients

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced top-line data from the randomized, double-blind, placebo-controlled Phase 2 study of...

Dec 01, 2014, 08:05 ET
KaloBios logo.

KaloBios Elects Robert A. Baffi, BioMarin Senior Executive, to Board of Directors

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the election of Robert A. Baffi, Ph.D. to the KaloBios Board of Directors. Dr....

Nov 11, 2014, 16:05 ET
KaloBios logo.

KaloBios Announces Upcoming Scientific and Investor Conference Participation

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that it will present at the Stifel 2014 Healthcare Conference in November, and...

Nov 06, 2014, 16:05 ET
KaloBios logo

KaloBios Reports Third Quarter Financial Results

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today reported its financial results for the third quarter of 2014. Net loss for the three...

Aug 14, 2014, 08:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

Publication by KaloBios and Collaborators Shows EphA3 as Target for Highly Selective Anticancer Therapy

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the publication of preclinical findings describing EphA3 as a novel target...

Aug 07, 2014, 08:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Provides Clinical Update and Reports Second Quarter Financial Results

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today provided an update on its current clinical programs and announced financial results for...

Jul 28, 2014, 16:01 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Provides Update on KB001-A Partnership and Clinical Status

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today provided an update on the status of the KB001-A development program, including an update on its...

Jun 11, 2014, 14:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios to Present at 9th Annual JMP Securities Healthcare Conference

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company will be presenting at the following investor conference: The...

May 21, 2014, 12:28 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios to Present at Jefferies 2014 Global Healthcare and BBC Boston CEO Conferences

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company will be presenting at the following investor conferences:...

May 08, 2014, 16:01 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Provides First Quarter 2014 Financial Results

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced financial results for the first quarter of 2014 and provided an update on its current...

May 06, 2014, 16:01 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

Ted W. Love, M.D., Named Chairman of the Board of KaloBios

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company's board of directors has elected Ted W. Love, M.D., as the...

Apr 03, 2014, 19:30 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Announces Upcoming Participation at Needham Healthcare Conference

 KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company will be presenting at the following upcoming investor...

Mar 13, 2014, 16:01 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Announces Fiscal Year 2013 Financial Results

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today provided an update on corporate accomplishments in fiscal 2013 and key milestones for 2014 as...

Mar 10, 2014, 16:01 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Announces Upcoming Participation at ROTH and BioCentury's Future Leaders in the Biotech Industry Conferences

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company will be presenting at the following upcoming investor...

Feb 11, 2014, 08:00 ET
KaloBios logo.  (PRNewsFoto/KaloBios)

KaloBios Initiates Phase 2 Expansion Portion of Study of KB004 in Hematologic Malignancies

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced that the company has begun treating patients in the Phase 2 expansion portion of...